Literature DB >> 10560521

Cytologic and DNA cytometric diagnosis and therapy monitoring of squamous cell carcinoma in situ and malignant melanoma of the cornea and conjunctiva.

B Nadjari1, A Kersten, B Ross, H Motherby, R Krallmann, R Sundmacher, A Böcking.   

Abstract

OBJECTIVE: To investigate the diagnostic accuracy of exfoliative cytology of the cornea and conjunctiva and DNA image cytometry for quality control and monitoring of therapy for malignant neoplasms. STUDY
DESIGN: Conjunctival or corneal smears from six cases clinically suspicious for malignant melanomas and eight suspicious for carcinomas in situ were investigated. Smears from 18 cases clinically nonsuspicious for neoplastic diseases served as negative controls. Repeated smears were obtained during and after local mitomycin C (MMC) therapy.
RESULTS: In none of 18 nonsuspicious cases, cytology revealed abnormal cells. DNA cytometry showed nonaneuploidy in all of these. All smears from patients with histologically proven malignant melanomas (MM) and squamous cell carcinomas in situ revealed abnormal cells. Image cytometry demonstrated DNA aneuploidy in 66.6% of patients with MM and 80% with carcinoma. Sensitivity of cytology thus was 100% for both MM and carcinoma; specificity also was 100%. DNA measurements after MMC therapy revealed euploid polyploidization of nonneoplastic squamous cells. DNA cytometry provided an objective identification of tumor cell regression.
CONCLUSION: Cytologic examination of corneal and conjunctival smears is a noninvasive tool with high diagnostic accuracy for detection of epithelial neoplasms. DNA image cytometry can serve for quality control and for objective monitoring of the effect of local chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560521

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  4 in total

1.  [33-year old female patient with "chronic conjunctivitis"].

Authors:  G Schilgen; T Reinhard; A Böcking; S Braunstein; R Sundmacher
Journal:  Ophthalmologe       Date:  2004-05       Impact factor: 1.059

2.  Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia.

Authors:  P A McKelvie; M Daniell
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

3.  Topical treatment options for conjunctival neoplasms.

Authors:  Jonathan W Kim; David H Abramson
Journal:  Clin Ophthalmol       Date:  2008-09

4.  [Atopic keratoconjunctivitis: probably a risk factor for the development of conjuntival carcinoma].

Authors:  C Kallen; T Reinhard; G Schilgen; O Cartsburg; A Böcking; C Auw-Hädrich; R Sundmacher
Journal:  Ophthalmologe       Date:  2003-10       Impact factor: 1.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.